| Literature DB >> 30836607 |
Horea Feier1,2, Dragos Cozma3, Marius Sintean4, Petre Deutsch5,6, Sorin Ursoniu7, Marian Gaspar8,9, Cristian Mornos10,11.
Abstract
(1) Background: Malperfusion is a central limiting factor in the setting of acute Type A aortic dissections (AAAD). We sought to find preoperative metabolic acidosis thresholds that might influence decision-making in this setting. (2)Entities:
Keywords: acidosis; aorta; dissection; malperfusion
Year: 2019 PMID: 30836607 PMCID: PMC6462918 DOI: 10.3390/jcm8030304
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Univariate preoperative risk assessment.
| Variable | Survivors % ( | Deceased % ( |
|
|---|---|---|---|
| Age >65 years | 18.2 (19) | 36.7 (18) | 0.01 |
| Male sex | 72.1 (75) | 63.2 (31) | 0.34 |
| Risk factors | |||
| Arterial hypertension | 79.8 (83) | 89.8 (44) | 0.16 |
| Diabetes | 5.7 (6) | 12.2 (6) | 0.20 |
| Body mass index | 28 ± 4.9 (104) | 29.92 ± 7 (49) | 0.21 |
| Marfan Syndrome | 3.8 (4) | 2.0 (1) | 1.00 |
| Bicuspid aortic valve | 10.5 (11) | 8.1 (4) | 0.77 |
| Redo procedure | 6.7 (7) | 2.0 (1) | 0.43 |
| Presentation | |||
| Pericardial fluid >10 mm | 27.8 (29) | 53 (26) | <0.01 |
| Severe aortic insufficiency | 37.5 (39) | 30.6 (15) | 0.47 |
| Aorta >5 cm | 58.6 (61) | 44.9 (22) | 0.12 |
| Ejection fraction | 54 ± 6.4 | 51.6 ± 6.2 | 0.03 |
| Entry site outside the ascending aorta | 14.4 (15) | 28.5 (14) | 0.04 |
| Malperfusion | |||
| Penn non Aa | 26.9 (28) | 59.1 (29) | <0.01 |
| Cardiogenic shock | 10.5 (11) | 36.7 (18) | <0.01 |
| Limb ischemia | 13.4 (14) | 22.4 (11) | 0.16 |
| Renal ischemia | 4.8 (5) | 4 (2) | 1.00 |
| Cerebral ischemia | 0.9 (1) | 6.1 (3) | 0.09 |
| Mesenteric ischemia | 0 (0) | 6.1 (3) | 0.03 |
| Lab values | |||
| Creatinine >1.7 mg/dL | 22.1 (23) | 40.8 (20) | 0.02 |
| Alanine aminotransferase (ALAT) | 89.38 ± 200 | 205.73 ± 450.23 | 0.13 |
| Aspartate aminotransferase (ASAT) | 113.16 ± 276.54 | 216.59 ± 472.16 | 0.23 |
| Acid base status | |||
| Prebypass base deficit | 3.63 ± 4.60 | 7.04 ± 6.70 | <0.01 |
| Prebypass pH | 7.34 ± 0.08 | 7.26 ± 0.13 | <0.01 |
Multivariate risk analysis for early death.
| Variable | Odds Ratio (OR) | VIF |
| 95% Confidence Interval (CI) | |
|---|---|---|---|---|---|
| Creatinine> 1.7 mg/dL | 1.28 | 1.31 | 0.59 | 0.51 | 3.22 |
| Hypertension | 1.70 | 1.14 | 0.40 | 0.47 | 6.08 |
| Age> 65 years | 2.4 | 1.06 | 0.06 | 0.96 | 5.96 |
| Ejection fraction | 0.96 | 1.09 | 0.33 | 0.90 | 1.03 |
| Cardiogenic shock | 3.30 | 1.48 | 0.03 | 1.10 | 9.82 |
| Entry site | 2.83 | 1.12 | 0.03 | 1.07 | 7.42 |
| Pericardial effusion >10 mm | 0.92 | 1.73 | 0.87 | 0.34 | 2.51 |
| Prebypass base deficit | 0.96 | 3.16 | 0.60 | 0.86 | 1.09 |
| Prebypass pH×100 | 0.93 | 2.96 | 0.02 | 0.87 | 0.98 |
| Malperfusion | 1.77 | 1.17 | 0.25 | 0.66 | 4.74 |
Figure 1Area under the receiver operating characteristic (ROC) curve of the logistic model.
Figure 2Kaplan–Meier curve depicting global survival of the entire cohort.
Cox regression analysis for early hazard phase (<30 days).
| Variable | Hazard Ratio (HR) |
| 95% CI | |
|---|---|---|---|---|
| Creatinine >1.7 mg/dL | 1.09 | 0.80 | 0.53 | 2.24 |
| Hypertension | 1.40 | 0.54 | 0.46 | 4.25 |
| Age >65 years | 1.50 | 0.24 | 0.75 | 2.99 |
| Ejection fraction | 0.98 | 0.47 | 0.93 | 1.02 |
| Cardiogenic shock | 1.25 | 0.60 | 0.53 | 2.94 |
| Entry site | 2.10 | 0.04 | 1.00 | 4.42 |
| Pericardial effusion >10 mm | 1.37 | 0.44 | 0.60 | 3.09 |
| Prebypass base deficit | 0.99 | 0.83 | 0.91 | 1.07 |
| Prebypass pH < 7.25 | 4.00 | <0.01 | 1.64 | 9.75 |
| Malperfusion | 1.91 | 0.10 | 0.87 | 4.20 |
Cox regression analysis for long-term (>30 days) hazard.
| Variable | Hazard Ratio |
| 95% CI | |
|---|---|---|---|---|
| Creatinine >1.7 mg/dL | 2.42 | 0.13 | 0.76 | 7.72 |
| Hypertension | 0.96 | 0.94 | 0.29 | 3.12 |
| Age >65 years | 3.12 | 0.02 | 1.17 | 8.31 |
| Ejection fraction | 0.94 | 0.08 | 0.88 | 1.00 |
| Cardiogenic shock | 0.28 | 0.27 | 0.03 | 2.62 |
| Entry site | 0.84 | 0.82 | 0.18 | 3.82 |
| Pericardial effusion >10 mm | 0.93 | 0.91 | 0.27 | 3.21 |
| Prebypass base deficit | 0.88 | 0.06 | 0.78 | 1.00 |
| Prebypass pH < 7.25 | 1.08 | 0.94 | 0.10 | 10.88 |
| Malperfusion | 1.40 | 0.51 | 0.50 | 3.92 |
Figure 3Kaplan–Meier curve for survival according to preoperative (prebypass) pH. A pH lower than 7.25 severely impacts early survival, but long-term (>30 days) survival is determined by other factors.